Elidel’s Claim on Its Better Efficacy over Protopic Now Challenged

In response to a recent announcement by Novartis on citing the favorable results for its Elidel (pimecrolimus) Cream 1% over Protopic (tacrolimus) Ointment 0.03%, a counter statement was recently made by the maker of Protopic.

Elidel’s claim on its advantages over Protopic were based on recently completed clinical study conducted by the American Academy of Dermatology (AAD), where both are n...